Investors looking at the semiconductor sector for AI-related opportunities often come across two contrasting companies: AEHR, a smaller equipment specialist focused on wafer-level and package-level burn-in testing, and ENTG, a larger supplier of materials and contamination-control products that serves the full chip manufacturing process. Both have gained from increased spending on artificial intelligence infrastructure, yet their risk profiles, valuations, and profitability levels differ noticeably. This comparison looks at their recent results and market positions to help investors decide which approach aligns better with current conditions.
Aehr Test Systems develops and markets test and burn-in systems, such as its FOX wafer-level and Sonoma package-level platforms, designed to identify early-life failures in semiconductor devices. Its business is closely tied to a limited group of customers in AI processors, silicon photonics, and power semiconductors. The company recently reported a significant turnaround, with quarterly revenue nearly tripling year over year to roughly $33 million, a shift to net income from a prior loss, and an updated full-year revenue target near $150 million. Bookings have outpaced revenue, building a record backlog. That said, the shares have shown sharp swings, including sizable drawdowns and sudden rebounds, and they continue to trade at a high price-to-sales ratio while posting negative trailing earnings per share. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Sentiment remains mixed between excitement over demand growth and concerns about customer concentration.
Entegris supplies high-purity materials, filtration systems, fluid handling, and contamination-control products used across semiconductor production for advanced logic, memory, and packaging. Its more diversified revenue comes from both consumables tied to production volumes and products linked to capital spending, giving it exposure throughout the chip cycle. Recent performance has been solid, with quarterly sales exceeding $1 billion, up about 25% year over year, and adjusted gross margins reaching their highest level in more than twenty years. Management expects continued double-digit growth and notes a backlog that has more than doubled from the prior year. Unlike AEHR, ENTG is profitable and produces meaningful cash flow, which has been applied to debt reduction. The shares have risen over the past year, though with some intermittent pullbacks.
The main difference between the two names lies in focus versus breadth. AEHR represents a concentrated position in a specialized equipment niche, which can drive rapid growth when AI-related testing demand rises but also magnifies losses if orders slow or a major customer reduces activity. Its recent revenue jump and backlog strength are notable, yet negative trailing earnings and a price-to-sales multiple above 30 times leave limited room for missteps. ENTG, on the other hand, operates at scale with exposure to logic, memory, and packaging; its growth is more consistent, margins sit at multi-year peaks, and it converts revenue into profits and free cash flow. Both stocks have moved higher over the past year, but ENTG has done so with noticeably lower volatility. The choice comes down to higher upside potential paired with elevated risk in AEHR versus greater resilience and stronger fundamentals in ENTG.
Considering factors such as trend consistency, earnings stability, diversification, and relative positioning, Tickeron's AI framework currently points to ENTG as the preferred name here. The assessment is based on probabilities rather than certainty: ENTG pairs positive momentum with confirmed profitability, expanding margins, and a wide customer base, supporting a more stable trend profile. AEHR presents an attractive yet more volatile growth narrative, with a premium valuation and greater dependence on a small set of customers. While both benefit from the same AI tailwinds, the AI-driven evaluation currently gives a modest advantage to ENTG for its blend of growth, profitability, and relative steadiness.
In my own research process, I often review how automated systems are handling names like these to add a data-driven layer to the analysis. One resource I turn to is Tickeron’s AI Trading Bots, which track positioning across thousands of tickers and highlight strategies suited to current conditions. AI Trading Bots can offer useful context when comparing stocks with different risk and growth characteristics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment